Ribeiro Ramiro 4

What Happened
Ramiro Ribeiro, Chief Medical Officer of EyePoint, exercised stock options to acquire 2,437 shares at $8.26 per share (cost $20,130) on April 17, 2026, and sold those 2,437 shares in an open-market transaction the same day at $15.00 per share, generating $36,555 in sale proceeds. The transactions reflect an immediate disposition of the shares acquired through option exercise.

Key Details

• Transaction date: 2026-04-17 (reported on Form 4 filed 2026-04-20).
• Option exercise: 2,437 shares acquired at $8.26 per share = $20,130 (transaction code M).
• Open-market sale: 2,437 shares sold at $15.00 per share = $36,555 (transaction code S).
• Report also lists a derivative disposition of 2,437 units at $0 (reflects conversion/cancellation of the option instrument on exercise).
• Net difference between sale proceeds and exercise cost: $36,555 − $20,130 = $16,425 (before fees/taxes).
• Vesting note: The option vests 25% as of Jan 3, 2026, with the remainder vesting monthly over the next three years (footnote F1).
• Shares owned after the transactions: not specified in the provided filing details.

Context
This was an exercise-and-sell (cashless-style) transaction: Ribeiro exercised vested options and immediately sold the underlying shares. Such transactions are common for executives to cover option exercise costs, taxes, or to diversify—facts only, no inference about future company performance. The filing date is April 20, 2026 for transactions dated April 17, 2026.